Ads
related to: multiple myeloma- Contact a Representative
For Questions and Information
About This Treatment
- Primary and Subgroup Data
Primary- and Subgroup-
Specific Data
- Phase 3 Trial
Explore the Phase 3 Trial Design,
Results, and Patient Population
- Patient Profile
Potential Treatment Candidates
HCPs, See Who May Be Appropriate
- Contact a Representative
Search results
Markey Cancer Center holds tenth annual ‘Expressions of Courage’
WKYT Lexington· 3 days agoLEXINGTON, Ky. (WKYT) -Markey Cancer Center celebrated their tenth annual “Expressions of Courage”...
California State Teachers Retirement System Purchases 60,431 Shares of Bristol-Myers Squibb...
ETF DAILY NEWS· 22 hours agoCalifornia State Teachers Retirement System grew its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.8% during the fourth quarter, according to its most recent 13F filing with ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoConcertAI: ASCO 2024 study indicates multi-AI model scalability key in streamlining of clinical trial site selection process PR Newswire CAMBRIDGE, Mass., May 30, 2024 CAMBRIDGE, Mass., May 30, 2024 /PRNewswire/ -- ConcertAI, the leader in oncology
Stifel Financial Corp Reduces Position in Genmab A/S (NASDAQ:GMAB)
ETF DAILY NEWS· 1 day agoStifel Financial Corp trimmed its holdings in shares of Genmab A/S (NASDAQ:GMAB – Free Report) by 5.0% during the fourth quarter, according to the company in its most recent Form 13F filing ...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 5 days agoSOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today
Q1 2024 Oncopeptides AB Earnings Call Transcript
Guru Focus· 5 days agoWith me, I have Henrik Bergentoft who will give a financial update. Before that, I will go over some key points for the first quarter, additionally some events in the second quarter. This, given ...
Ad
related to: multiple myeloma